台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.30
  • 漲跌
    ▼0.40
  • 漲幅
    -0.94%
  • 成交量
    132
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-元大-台北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-台北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2100.00241.8542.70-2344-0.58%
2025/01/09145.15143.9543.9503860.00%
2025/01/0800.00143.0042.70-1384-0.26%
2024/12/27045.9000.0044.2504210.01%
2024/12/26144.5500.0044.0514290.23%
2024/11/20245.4500.0045.1026820.29%
2024/11/18145.00144.1044.1006990.00%
2024/11/14146.5000.0046.4517050.14%
2024/11/12147.9000.0047.3517260.14%
2024/10/2900.00153.5052.10-1772-0.13%
2024/10/281653.541655.1152.6007560.00%
2024/10/25253.3500.0054.4026450.31%
2024/10/2100.00249.6049.90-2660-0.30%
2024/10/170.151.0000.0050.500.18500.01%
2024/10/16049.8500.0050.6009610.00%
2024/10/08051.7000.0050.8001,0520.00%
2024/09/241153.401154.6053.4001,0190.00%
2024/09/23754.60756.2054.6001,0190.00%
2024/09/20155.00154.2055.0001,0230.00%
2024/09/194.154.901755.8853.20-13995-1.30%
2024/09/181552.2900.0052.30159431.59%
2024/09/1300.00148.0047.80-1967-0.10%
2024/09/09248.75248.2048.2001,0340.00%
2024/09/06147.1000.0046.5511,0230.10%
2024/08/1400.00147.0547.05-1901-0.11%
2024/08/1300.00147.4547.10-1894-0.11%
2024/08/09150.50148.3548.1508790.00%
2024/08/0600.00148.7049.00-1841-0.12%
2024/07/29157.50158.8056.9007880.00%
2024/07/22157.21159.5956.2007520.00%
2024/07/19460.95558.8458.10-1735-0.14%
2024/07/182461.152262.8462.2026580.30%
2024/07/174958.985957.9358.90-10543-1.84%
2024/07/161856.989.156.4557.208.94272.08%
2024/07/15252.001752.0052.00-15337-4.45%
2024/07/121747.3000.0047.30173285.17%
2024/06/27148.5000.0047.1012960.34%
2024/06/2600.00149.0048.75-1288-0.35%
2024/04/2600.00140.7040.70-1182-0.55%
2024/04/02143.80243.6043.95-1192-0.52%
2024/03/29144.0500.0044.1011980.50%
2024/03/2000.00241.3341.55-2198-1.01%
2024/03/1900.00341.8741.65-3199-1.50%
2024/03/18242.3300.0042.2521991.00%
2024/03/15142.7500.0042.9012000.50%
2024/03/14242.9000.0042.9022050.97%
2024/03/07242.78442.5543.55-2322-0.62%
2024/03/06143.65244.3543.40-1331-0.30%
2024/03/05343.8300.0043.8033350.90%
2024/03/01045.0000.0044.2503440.00%
2024/02/2900.00144.9544.85-1366-0.27%
2024/02/27345.43345.5045.0003730.00%
2024/02/26245.15145.3045.8013790.26%
2024/02/2300.00545.0044.95-5394-1.27%
2024/02/22145.501045.5545.25-9398-2.26%
2024/02/2100.00545.8545.80-5406-1.23%
2024/02/2000.00246.0345.70-2411-0.49%
2024/02/19146.65146.7046.5504170.00%
2024/02/16345.93346.4246.7504260.00%
2024/02/1500.00346.3046.00-3436-0.69%
2024/02/05346.3700.0046.1534450.67%
2024/01/31246.9300.0047.0025520.36%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音